BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...its first day of trading Monday. The deal valued Jacobio at HK$10.6 billion ($1.4 billion). Hillhouse Capital...
BioCentury | Dec 15, 2020
Deals

Hillhouse’s Overland builds momentum with second marquee China deal with Allogene

...Inc. and Biogen Inc. (NASDAQ:BIIB). Jeff Cranmer Overland Pharmaceuticals Allogene Therapeutics Hillhouse Capital chs2020 bee2021...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...focuses on iron deficiency, pain management and respiratory disease.Hillhouse’s Mu and Zhang launch start-up OverlandBacked by Hillhouse Capital...
...to classify and sort cells. TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse Capital Pear...
BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...Shanghai cancer company during which it has rebooted its C-suite, added dry powder via a Hillhouse Capital-led...
BioCentury | Sep 5, 2020
Deals

Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders

...its coffers through a CD47 licensing deal with AbbVie and a PIPE financing led by Hillhouse Capital.The...
BioCentury | Jul 13, 2020
Finance

BeiGene’s billions to support new launches, deep pipeline

...an investor presentation last week. The biotech named Amgen Inc. (NASDAQ:AMGN), Baker Bros. Advisors and Hillhouse Capital...
...T cell immunoreceptor with Ig and ITIM domains Paul Bonanos, Associate Editor BeiGene Ltd. Amgen Inc. Baker Brothers Advisors Hillhouse Capital chs20...
BioCentury | Jun 4, 2020
Finance

Everest to fund late-stage trials with $310M mountain of fresh cash

...Janchor Partners led its $260 million series C-2 equity round, which also included RA Capital, Hillhouse Capital...
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...a new indication after raising a $160 million series B round led by existing investor Hillhouse Capital...
BioCentury | Apr 9, 2020
Finance

As Tango moves toward clinic with $60M series B, another partnership could precede IPO

...Capital of the Tavistock Group, Tango’s new round includes Cormorant Asset Management, Casdin Capital and Hillhouse Capital...
BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...The round was jointly led by China venture capital fund, CICC Qide Fund and the Hillhouse Capital...
Items per page:
1 - 10 of 88
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...its first day of trading Monday. The deal valued Jacobio at HK$10.6 billion ($1.4 billion). Hillhouse Capital...
BioCentury | Dec 15, 2020
Deals

Hillhouse’s Overland builds momentum with second marquee China deal with Allogene

...Inc. and Biogen Inc. (NASDAQ:BIIB). Jeff Cranmer Overland Pharmaceuticals Allogene Therapeutics Hillhouse Capital chs2020 bee2021...
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...focuses on iron deficiency, pain management and respiratory disease.Hillhouse’s Mu and Zhang launch start-up OverlandBacked by Hillhouse Capital...
...to classify and sort cells. TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse Capital Pear...
BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...Shanghai cancer company during which it has rebooted its C-suite, added dry powder via a Hillhouse Capital-led...
BioCentury | Sep 5, 2020
Deals

Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders

...its coffers through a CD47 licensing deal with AbbVie and a PIPE financing led by Hillhouse Capital.The...
BioCentury | Jul 13, 2020
Finance

BeiGene’s billions to support new launches, deep pipeline

...an investor presentation last week. The biotech named Amgen Inc. (NASDAQ:AMGN), Baker Bros. Advisors and Hillhouse Capital...
...T cell immunoreceptor with Ig and ITIM domains Paul Bonanos, Associate Editor BeiGene Ltd. Amgen Inc. Baker Brothers Advisors Hillhouse Capital chs20...
BioCentury | Jun 4, 2020
Finance

Everest to fund late-stage trials with $310M mountain of fresh cash

...Janchor Partners led its $260 million series C-2 equity round, which also included RA Capital, Hillhouse Capital...
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...a new indication after raising a $160 million series B round led by existing investor Hillhouse Capital...
BioCentury | Apr 9, 2020
Finance

As Tango moves toward clinic with $60M series B, another partnership could precede IPO

...Capital of the Tavistock Group, Tango’s new round includes Cormorant Asset Management, Casdin Capital and Hillhouse Capital...
BioCentury | Apr 8, 2020
Finance

Suzhou Ribo raises $66.3M for nucleic acid therapies

...The round was jointly led by China venture capital fund, CICC Qide Fund and the Hillhouse Capital...
Items per page:
1 - 10 of 88